168 related articles for article (PubMed ID: 32421920)
21. Expression of CD44 in canine mammary tumours.
Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
[TBL] [Abstract][Full Text] [Related]
22. Expression of Ccdc85C, a causative protein for murine hydrocephalus, in the mammary gland tumors of dogs.
Tanaka N; Izawa T; Takenaka S; Akiyoshi H; Yamate J; Kuwamura M
Histol Histopathol; 2017 Apr; 32(4):397-403. PubMed ID: 27457231
[TBL] [Abstract][Full Text] [Related]
23. Isolation, purification, culture and characterisation of myoepithelial cells from normal and neoplastic canine mammary glands using a magnetic-activated cell sorting separation system.
Sánchez-Céspedes R; Maniscalco L; Iussich S; Martignani E; Guil-Luna S; De Maria R; Martín de Las Mulas J; Millán Y
Vet J; 2013 Aug; 197(2):474-82. PubMed ID: 23583698
[TBL] [Abstract][Full Text] [Related]
24. Myoepithelial cells in canine mammary tumours.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; Reymundo C; Espinosa de Los Monteros A; Martín de Las Mulas J
Vet J; 2016 Jan; 207():45-52. PubMed ID: 26639832
[TBL] [Abstract][Full Text] [Related]
25. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
PeerJ; 2024; 12():e17077. PubMed ID: 38500523
[TBL] [Abstract][Full Text] [Related]
27. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic profile reveals molecular events associated to focal adhesion and invasion in canine mammary gland tumour cell lines.
Cordeiro YG; Xavier PLP; Rochetti AL; Alexandre PA; Mori CMC; Strefezzi RF; Fukumasu H
Vet Comp Oncol; 2018 Mar; 16(1):E89-E98. PubMed ID: 28834169
[TBL] [Abstract][Full Text] [Related]
29. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
30. Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases.
Ressel L; Millanta F; Poli A
J Comp Pathol; 2011 May; 144(4):303-7. PubMed ID: 20961557
[TBL] [Abstract][Full Text] [Related]
31. Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours.
Chang SC; Yuan SH; Li CY; Chang HM; Wang HC; Pan YA; Hsueh PC; Wu CC; Yang Y; Liu HP
Vet Comp Oncol; 2021 Mar; 19(1):172-182. PubMed ID: 33038064
[TBL] [Abstract][Full Text] [Related]
32. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y
Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526
[TBL] [Abstract][Full Text] [Related]
33. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
Gattino F; Maniscalco L; Iussich S; Biasato I; Martano M; Morello E; Gola C; Millán Ruiz Y; Saeki N; Buracco P; Martín de Las Mulas J; De Maria R
Vet Rec; 2018 Aug; 183(7):221. PubMed ID: 29440590
[TBL] [Abstract][Full Text] [Related]
34. Expression of stratified squamous epithelia-type cytokeratin by canine mammary epithelial cells during tumorigenesis: type I (acidic) 57 kilodalton cytokeratin could be a molecular marker for malignant transformation of mammary epithelial cells.
Arai K; Kaneko S; Naoi M; Suzuki K; Maruo K; Uehara K
J Vet Med Sci; 1994 Feb; 56(1):51-8. PubMed ID: 7515697
[TBL] [Abstract][Full Text] [Related]
35. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
36. Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours.
Guimarães MJ; Carvalho MI; Pires I; Prada J; Gil AG; Lopes C; Queiroga FL
J Comp Pathol; 2014 Jan; 150(1):27-34. PubMed ID: 24060154
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
39. Canine mammary tumour cell lines established in vitro.
Hellmén E
J Reprod Fertil Suppl; 1993; 47():489-99. PubMed ID: 8229968
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours.
Rabanal RM; Else RW
Res Vet Sci; 1994 Mar; 56(2):225-33. PubMed ID: 7514803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
